Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-14EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
EMA has authorized Qaialdo, a spironolactone product by Lipomed GmbH, for several conditions including edema, heart failure, liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: Single-Session Extraoral PBM After Third Molar Extraction [NA]
Clinical trial results for a single-session extraoral photobiomodulation therapy following third molar extraction, completed with posted res…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Single-Session Extraoral PBM After Third Molar Extraction [NA]
A clinical trial assessed a single-session extraoral photobiomodulation treatment after impacted mandibular third molar extraction to reduce…
-
EMA approval · 2026-03-24EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
Qaialdo is a spironolactone product by Lipomed GmbH that has been authorized in the EU. Indications include edema, heart failure, liver cirr…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre [NA]
A clinical trial is evaluating the effects of red and infrared photobiomodulation in rhinoplasty at a single center and is currently recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure [Phase 4]
A Phase 4 trial comparing the natriuretic effects of extended-release torsemide versus immediate-release torsemide in patients with heart fa…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Measuring Fluid Buildup in Cancer Patients
A clinical trial update describes a study measuring fluid buildup in cancer patients using bioelectrical impedance and edema-related assessm…
-
CLINICAL_TRIALS other · 2026-03-02Clinical Trial Update: Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients [NA]
A clinical trial update notes a care bundle aimed at preventing skin complications and edema in patients subjected to physical restraints; t…
-
FDA approval · 2026-01-08FDA Approved: FUROSEMIDE — Original Application (Micro Labs Limited)
FDA approved the original application for furosemide from Micro Labs Limited.
-
FDA approval · 2026-01-07FDA Approved: METOLAZONE — Supplemental Application (Method Pharmaceuticals, LLC)
The FDA approved a supplemental application for METOLAZONE submitted by Method Pharmaceuticals, LLC.
-
FDA approval · 2025-12-22FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc.)
The FDA approved a supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) from scPharmaceuticals Inc.
-
FDA approval · 2025-11-14FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Aldactone (spironolactone) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2025-11-14FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for Spironolactone and Hydrochlorothiazide, a combination diuretic. This re…
-
FDA approval · 2025-10-07FDA Approved: LASIX ONYU — Original Application (SQ Innovation, Inc.)
FDA approves LASIX ONYU for the same active ingredient furosemide under an Original Application by SQ Innovation, Inc. The product is now au…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Diuretic Tuner Clinical Decision Support [NA]
A clinical trial update indicates that a Diuretic Tuner Clinical Decision Support tool is currently recruiting at UT Southwestern Medical Ce…
-
FDA approval · 2025-09-08FDA Approved: FUROSEMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for furosemide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., updating/expandin…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture. [NA]
Completed clinical trial evaluating taping to control edema in patients with forearm plaster for a wrist fracture; results have been posted.
-
FDA approval · 2025-08-06FDA Approved: FUROSEMIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic diuretic furosemide from Meitheal Pharmaceuticals Inc. under ANDA 212803.
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
FDA approval · 2025-07-17FDA Approved: FUROSEMIDE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original ANDA for furosemide, a generic loop diuretic. The approval covers the generic product for i…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures [NA]
A clinical trial update indicates Venostan is being studied for its ability to reduce postoperative swelling in patients with ankle fracture…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Lymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema [NA]
This clinical trial is evaluating lymphatic drainage massage and melatonin for post-orthognathic surgery pain and edema and is currently enr…
-
FDA approval · 2025-06-17FDA Approved: ACETAZOLAMIDE — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' Original Application for Acetazolamide, including Acetazolamide and Acetazolamide Sodium formulations.
-
FDA approval · 2025-05-08FDA Approved: FUROSEMIDE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for furosemide by Eugia US LLC under an ANDA, confirming approval of the supplement.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: COMPARISON OF BANDAGE IN HAND EDEMA [NA]
This clinical trial update describes a study evaluating bandaging for hand edema, currently enrolling by invitation in the Veneto region.